BeiGene Ltd (BGNE)
153.68
+5.12
(+3.45%)
USD |
NASDAQ |
Apr 26, 14:50
BeiGene Revenue (TTM): 2.459B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.459B |
| September 30, 2023 | 2.204B |
| June 30, 2023 | 1.811B |
| March 31, 2023 | 1.557B |
| December 31, 2022 | 1.416B |
| September 30, 2022 | 1.250B |
| June 30, 2022 | 1.069B |
| March 31, 2022 | 877.04M |
| December 31, 2021 | 1.176B |
| September 30, 2021 | 1.062B |
| June 30, 2021 | 947.04M |
| March 31, 2021 | 862.69M |
| December 31, 2020 | 308.87M |
| September 30, 2020 | 265.67M |
| June 30, 2020 | 224.73M |
| March 31, 2020 | 402.44M |
| December 31, 2019 | 428.21M |
| September 30, 2019 | 429.99M |
| Date | Value |
|---|---|
| June 30, 2019 | 434.05M |
| March 31, 2019 | 243.51M |
| December 31, 2018 | 198.22M |
| September 30, 2018 | 157.72M |
| June 30, 2018 | 323.74M |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | 7.127M |
| March 31, 2016 | 8.114M |
| December 31, 2015 | 8.816M |
| September 30, 2015 | 5.52M |
| June 30, 2015 | 10.64M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
224.73M
Minimum
Jun 2020
2.459B
Maximum
Dec 2023
1.010B
Average
947.04M
Median
Jun 2021
Revenue (TTM) Benchmarks
| Theravance Biopharma Inc | 57.42M |
| LumiraDx Ltd | 126.52M |
| ASLAN Pharmaceuticals Ltd | -- |
| Zai Lab Ltd | 266.72M |
| Legend Biotech Corp | 285.14M |